These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 576532)

  • 1. Vasoactive intestinal peptide (VIP): variation of the jejuno-ileal content in the developing rat as measured by radioreceptorassay.
    Laburthe M; Bataille D; Rosselin G
    Acta Endocrinol (Copenh); 1977 Mar; 84(3):588-99. PubMed ID: 576532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vasoactive intestinal peptide receptor-effector system is developmentally regulated in rat jejuno-ileal epithelial cells.
    Fernandez-Moreno MD; Diaz-Juarez JL; Fernandez-Gonzalez MA; Sanchez-Franco F; Prieto JC
    Biochem Int; 1988 Feb; 16(2):331-7. PubMed ID: 2835052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon, secretin and vasoactive intestinal polypeptide immunoreactivities in rat gut after jejuno-ileal bypass and resection.
    Murphy RF; Chen MH; Herlin PM; Gallavan RH; Joffe SN; Fischer JE
    Digestion; 1985; 32(2):106-13. PubMed ID: 4043560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptor.
    Couvineau A; Laburthe M
    Biochem J; 1985 Jan; 225(2):473-9. PubMed ID: 3977841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of vasoactive intestinal peptide, cholecystokinin and calcitonin gene-related peptide in plasma and jejunum of rats following traumatic brain injury and underlying significance in gastrointestinal dysfunction.
    Hang CH; Shi JX; Li JS; Wu W; Li WQ; Yin HX
    World J Gastroenterol; 2004 Mar; 10(6):875-80. PubMed ID: 15040036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of vasoactive intestinal peptide receptors in canine liver membranes.
    Kiso T; Ito S; Ohta T; Asano T; Nakazato Y
    Biochem Pharmacol; 1994 Jan; 47(2):241-5. PubMed ID: 8304967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubilization and hydrodynamic characterization of guanine nucleotide sensitive vasoactive intestinal peptide-receptor complexes from rat intestine.
    Calvo JR; Couvineau A; Guijarro L; Laburthe M
    Biochemistry; 1989 Feb; 28(4):1667-72. PubMed ID: 2541761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective photolabeling of high and low affinity binding sites for vasoactive intestinal peptide (VIP): evidence for two classes of covalent VIP-receptor complexes in intestinal cell membranes.
    Robichon A; Marie JC
    Endocrinology; 1987 Mar; 120(3):978-85. PubMed ID: 3026793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vip in human neonates and infants. As measured by radioimmunoassay and radioreceptorassay (author's transl)].
    Dupont C; Besson J; Laburthe M; Bataille D; Rosselin G
    Ann Endocrinol (Paris); 1977; 38(2):151-2. PubMed ID: 197870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
    Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M
    Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor binding of guinea pig and pig vasoactive intestinal peptides by rat lung.
    Paul S; Volle DJ; Currie J
    Biochem J; 1988 Sep; 254(2):613-5. PubMed ID: 2845959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
    Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative studies of vasoactive intestinal peptide (VIP) binding sites and VIP-induced adenosine 3':5'-monophosphate production in epithelial cells from duodenum, jejunum, ileum, cecum, colon and rectum in the rat.
    Prieto JC; Laburthe M; Hoa DH; Rosselin G
    Acta Endocrinol (Copenh); 1981 Jan; 96(1):100-6. PubMed ID: 6257013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
    Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
    Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes.
    Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R
    Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogenic development of vasoactive intestinal peptide receptors in rat intestinal cells and liver.
    Chastre E; Emami S; Rosselin G; Gespach C
    Endocrinology; 1987 Dec; 121(6):2211-21. PubMed ID: 2824182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of GRF with VIP receptors and stimulation of adenylate cyclase in rat and human intestinal epithelial membranes. Comparison with PHI and secretin.
    Laburthe M; Amiranoff B; Boige N; Rouyer-Fessard C; Tatemoto K; Moroder L
    FEBS Lett; 1983 Aug; 159(1-2):89-92. PubMed ID: 6307754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of vasoactive intestinal peptide in the control of prolactin-induced turkey incubation behavior. II. Chronic infusion of vasoactive intestinal peptide.
    Pitts GR; Youngren OM; Silsby JL; Rozenboim I; Chaiseha Y; Phillips RE; Foster DN; el Halawani ME
    Biol Reprod; 1994 Jun; 50(6):1350-6. PubMed ID: 8080923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.